![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
01 DAPIPRAZOLE HYDROCHLORIDE (1)
02 FLUCONAZOLE (5)
03 MILRINONE LACTATE (2)
04 MIVACURIUM CHLORIDE (2)
05 NANDROLONE DECANOATE (3)
06 OMEGA-3-ACID ETHYL ESTERS (1)
07 ROSIGLITAZONE MALEATE (3)
01 CAPSULE;ORAL (1)
02 INJECTABLE;INJECTION (10)
03 SOLUTION/DROPS;OPHTHALMIC (1)
04 SOLUTION;INTRAVENOUS (2)
05 TABLET;ORAL (3)
01 0.5% (1)
02 100MG/50ML (2MG/ML) (1)
03 100MG/ML (1)
04 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS (1)
05 200MG/100ML (2MG/ML) (2)
06 200MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
07 400MG/200ML (2MG/ML) (2)
08 50MG/ML (1)
09 EQ 10MG BASE/5ML (EQ 2MG BASE/ML) (1)
10 EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) (1)
11 EQ 20MG BASE/10ML (EQ 2MG BASE/ML) (1)
12 EQ 2MG BASE (1)
13 EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) (1)
14 EQ 4MG BASE (1)
15 EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
01 DISCN (13)
02 RX (4)